Patrick Soon-Shiong

Patrick Soon-Shiong: Promising NK Cell and Bioshield Breakthrough for Waldenstrom’s

Patrick Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:

“Waldenstrom’s, a rare form of lymphoma, where tumor cells can take over 90 percent of the bone marrow – patients at this stage of disease, when all treatment fails, are at life-threatening danger. News on the power of NK cells and Bioshield platform to the rescue coming soon.”

More posts featuring Pat Soon-Shiong.